Cargando…

Hiper IgD syndrome (HIDS): clinical and genetic features in five patients

Detalles Bibliográficos
Autores principales:	Marco, A, Calvo, I, Lopez, B, Arostegui, JI, Yagüe, J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334002/ http://dx.doi.org/10.1186/1546-0096-6-S1-P199

Ejemplares similares

Long-term efficacy and safety of Canakinumab in active Hyper-IgD syndrome (HIDS): results from an open-label study
por: Aróstegui, JI, et al.
Publicado: (2015)

Interleukin 1 blockade withcanakinumab for Hyper IGD syndrome (HIDS)
por: Brunnner, J, et al.
Publicado: (2015)

PReS-FINAL-2330: Canakinumab treatment in patients with HIDS
por: Antón, J, et al.
Publicado: (2013)

The clinical and genetic features of patients with hyper-immunoglobulin D syndrome (HIDS)
por: Sozeri, Betul, et al.
Publicado: (2014)

Hyper-IgD syndrome: a new mutation (p.R277G) with a severe phenotype
por: Santos, J, et al.
Publicado: (2011)

Hyper Immunoglobulin D syndrome (HIDS): understanding what it is like to live with this rare condition
por: Dandekar, P, et al.
Publicado: (2015)

PReS-FINAL-2239: Renal AA amyloidosis in a child with hyper-IgD syndrome and a novel MVK mutation
por: Fingerhutova, S, et al.
Publicado: (2013)

Physiology of IgD. IV. Enhancement of antibody production in mice bearing IgD-secreting plasmacytomas
Publicado: (1984)

Expression of IgD by murine lymphocytes. Loss of surface IgD indicates maturation of memory B cells
Publicado: (1978)

Physiology of IgD. VI. Transfer of the immunoaugmenting effect of IgD with T delta-containing helper cell populations
Publicado: (1985)

Identification of unfavourable paired cell interactions in follicular lymphoma using hypothesized interaction distribution (HID) analysis
por: Mansfield, James, et al.
Publicado: (2014)

Physiology of IgD. I. Compensatory phenomena in B lymphocyte activation in mice treated with anti-IgD antibodies
Publicado: (1981)

Differential Expression of IgM and IgD Discriminates Two Subpopulations of Human Circulating IgM(+)IgD(+)CD27(+) B Cells That Differ Phenotypically, Functionally, and Genetically
por: Bautista, Diana, et al.
Publicado: (2020)

Anaplastic morphology in IgD multiple myeloma
por: Roldán Galiacho, Verónica, et al.
Publicado: (2023)

Immunoglobulin D (IgD)-deficient mice reveal an auxiliary receptor function for IgD in antigen-mediated recruitment of B cells
Publicado: (1993)

Teleost IgD(+)IgM(−) B Cells Mount Clonally Expanded and Mildly Mutated Intestinal IgD Responses in the Absence of Lymphoid Follicles
por: Perdiguero, Pedro, et al.
Publicado: (2019)

Detection of intracellular IgD using flow cytometry could be a novel and supplementary method to diagnose IgD multiple myeloma
por: Wang, Wei, et al.
Publicado: (2018)

AL Amyloidosis in a Patient with IgD Myeloma
por: Rafik, Hicham, et al.
Publicado: (2020)

Follow-up of IgD-κ multiple myeloma by monitoring free light chains and total heavy chain IgD: A case report
por: De Santis, Elena, et al.
Publicado: (2016)

血清IgD定量检测在IgD型多发性骨髓瘤患者疗效评估中的价值
Publicado: (2016)

Heat Treatment of High-Performance Ferritic (HiperFer) Steels
por: Kuhn, Bernd, et al.
Publicado: (2023)

Ontogeny of Ia and IgD on IgM-bearing B lymphocytes in mice
Publicado: (1977)

IgD myeloma/immunoblastic lymphoma cells expressing cytokeratin.
por: Sewell, H. F., et al.
Publicado: (1986)

Excess IgD Bearing Lymphocytes in Patients with Malignant Melanoma
por: Malka, S., et al.
Publicado: (1974)

The role of surface IgD in the response to thymic-independent antigens
Publicado: (1977)

IgD Multiple Myeloma Paraproteinemia as a Cause of Myositis
por: Colombo, I., et al.
Publicado: (2010)

Nummular keratopathy in a patient with Hyper-IgD Syndrome
por: Kraus, Courtney L, et al.
Publicado: (2009)

Aggressive FLC Escape in a Patient with IgD Myeloma
por: Farges, Cédric, et al.
Publicado: (2015)

The remnant of the European rabbit (Oryctolagus cuniculus) IgD gene
por: Lanning, Dennis K., et al.
Publicado: (2017)

Primary Immune Responses and Affinity Maturation Are Controlled by IgD
por: Amendt, Timm, et al.
Publicado: (2021)

Clinical characteristics and survival of patients with IgD multiple myeloma
por: Li, Yi, et al.
Publicado: (2021)

Teleost IgD(+)IgM(−) B cells in gills and skin have a plasmablast profile, but functionally and phenotypically differ from IgM(+)IgD(−) B cells in these sites
por: Herranz-Jusdado, J. Germán, et al.
Publicado: (2023)

Clinical and genetic features of Spanish patients with Mevalonate kinase deficiency
por: Ruiz-Ortiz, E, et al.
Publicado: (2015)

Activation of the pyrin inflammasome through the RhoA signaling pathway in FMF and HIDS
por: Park, YH, et al.
Publicado: (2015)

Atypical manifestations in CAPS sydrome: not so unfrequent?
por: Buján-Rivas, S, et al.
Publicado: (2015)

OCCURRENCE OF SURFACE IgM, IgD, AND FREE LIGHT CHAINS ON HUMAN LYMPHOCYTES
por: Fu, Shu Man, et al.
Publicado: (1974)

N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma
por: Chen, Jie, et al.
Publicado: (2017)

Clinical features and survival outcomes in IgD myeloma: a study by Asia Myeloma Network (AMN)
por: Liu, Jin, et al.
Publicado: (2020)

IgD-Fc-Ig fusion protein, a new biological agent, inhibits T cell function in CIA rats by inhibiting IgD-IgDR-Lck-NF-κB signaling pathways
por: Han, Le, et al.
Publicado: (2020)

A Case of Hyper IgD and Periodic Fever Syndrome in Japan
por: Kawashima, Hisashi, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_l2e3pj2cuvtlv9l206d5an86e3